{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:01:32Z","timestamp":1776747692651,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaip.2023.01.036","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:51:17Z","timestamp":1675374677000},"page":"1503-1508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature"],"prefix":"10.1016","volume":"11","author":[{"given":"Syed B.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-i","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh-Thao Adriana","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.01.036_bib2","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa070594","article-title":"Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma","volume":"357","author":"Dimopoulos","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.036_bib3","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3109\/10428194.2016.1151507","article-title":"Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma","volume":"57","author":"Barley","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2023.01.036_bib4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jcpt.13433","article-title":"Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: case series","volume":"46","author":"Sugi","year":"2021","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jaip.2023.01.036_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ajh.21004","article-title":"Successful desensitization in a patient with lenalidomide hypersensitivity","volume":"82","author":"Phillips","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2023.01.036_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.12925","article-title":"Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma","volume":"167","author":"Lee","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2023.01.036_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23822\/EurAnnACI.1764-1489.134","article-title":"Successful desensitization procedure to lenalidomide in a patient with delayed hypersensitivity confirmed with a positive LTT","volume":"52","author":"Lazzarato","year":"2020","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.036_bib8","first-page":"807","article-title":"Lenalidomide desensitization in systemic light-chain amyloidosis with multi-organ involvement","volume":"7","author":"Seki","year":"2015","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.jaip.2023.01.036_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.18176\/jiaci.0386","article-title":"Delayed hypersensitivity reaction to lenalidomide: 2 different clinical patterns in the same patient","volume":"29","author":"Noguerado-Mellado","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.036_bib10","first-page":"542","article-title":"Desensitization to lenalidomide [in Spanish]","volume":"36","author":"Orbis","year":"2012","journal-title":"Farm Hosp"},{"key":"10.1016\/j.jaip.2023.01.036_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clml.2012.09.003","article-title":"Desensitization to lenalidomide in a patient with relapsed multiple myeloma","volume":"13","author":"Seki","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaip.2023.01.036_bib12","first-page":"A78","article-title":"CP-174 Successful desensitisation in a patient with lenalidomide hypersensitivity","volume":"24","author":"Baptista","year":"2017","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.jaip.2023.01.036_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bulcan.2017.06.014","article-title":"Lenalidomide desensitization in a patient with 5q- syndrome [in French]","volume":"104","author":"Boudin","year":"2017","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jaip.2023.01.036_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.anai.2019.07.031","article-title":"A\u00a0practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions","volume":"123","author":"Demir","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.036_bib15","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1080\/10428194.2019.1627537","article-title":"Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center","volume":"60","author":"Yau","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2023.01.036_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clml.2013.03.006","article-title":"Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysis","volume":"13","author":"Nardone","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaip.2023.01.036_bib17","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1182\/bloodadvances.2019001410","article-title":"Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses","volume":"4","author":"Phan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2023.01.036_bib18","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/10428194.2019.1608531","article-title":"Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score\u2013matched multi-institutional cohort study","volume":"60","author":"Dote","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2023.01.036_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2015.05.002","article-title":"Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy","volume":"297","author":"Scott","year":"2015","journal-title":"Cell Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:17Z","timestamp":1761975377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213219823001228"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.036","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}